CORRECTION: Atea Pharmaceuticals Q3 EPS $(0.40) Beats $(0.42) Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Beats
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 24.53 percent increase over losses of $(0.53) per share
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 24.53 percent increase over losses of $(0.53) per share from the same period last year.